JPS5294431A - Antiivirus agent treatment for virus inffction and prevention method - Google Patents

Antiivirus agent treatment for virus inffction and prevention method

Info

Publication number
JPS5294431A
JPS5294431A JP14789976A JP14789976A JPS5294431A JP S5294431 A JPS5294431 A JP S5294431A JP 14789976 A JP14789976 A JP 14789976A JP 14789976 A JP14789976 A JP 14789976A JP S5294431 A JPS5294431 A JP S5294431A
Authority
JP
Japan
Prior art keywords
inffction
antiivirus
virus
prevention method
agent treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP14789976A
Other languages
Japanese (ja)
Other versions
JPS6120525B2 (en
Inventor
Kuroodo Shieruman Jiyan
Jiyasumin Kuroodo
Maasu Jiyorujiyu
Reinoo Maruseru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7605084A external-priority patent/FR2334366A2/en
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Publication of JPS5294431A publication Critical patent/JPS5294431A/en
Publication of JPS6120525B2 publication Critical patent/JPS6120525B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G41/00—Compounds of tungsten
    • C01G41/006—Compounds containing, besides tungsten, two or more other elements, with the exception of oxygen or hydrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00—Crystal-structural characteristics
    • C01P2002/80—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70
    • C01P2002/82—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70 by IR- or Raman-data
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/60—Optical properties, e.g. expressed in CIELAB-values

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP14789976A 1975-12-10 1976-12-10 Antiivirus agent treatment for virus inffction and prevention method Granted JPS5294431A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63941375A 1975-12-10 1975-12-10
FR7605084A FR2334366A2 (en) 1975-12-10 1976-02-24 9-Antimonic-(21)-tungsto-sodate heteropolyanions - pref. as the ammonium or metal salts are antivirals synergistic with interferon, active against leukaemia and sarcoma viruses

Publications (2)

Publication Number Publication Date
JPS5294431A true JPS5294431A (en) 1977-08-09
JPS6120525B2 JPS6120525B2 (en) 1986-05-22

Family

ID=26219311

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14789976A Granted JPS5294431A (en) 1975-12-10 1976-12-10 Antiivirus agent treatment for virus inffction and prevention method

Country Status (2)

Country Link
JP (1) JPS5294431A (en)
GB (1) GB1573002A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6163619A (en) * 1984-09-04 1986-04-01 Hiroyuki Kasano Drug
JPS61227525A (en) * 1984-12-03 1986-10-09 アンスチチュ　パストゥール Therapeutical medicine for acquired immunological dysfunction syndrome, pharmacological composition and therapy
JPS6438022A (en) * 1987-08-03 1989-02-08 Haruhisa Fujita Antiviral agent

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6163619A (en) * 1984-09-04 1986-04-01 Hiroyuki Kasano Drug
JPS61227525A (en) * 1984-12-03 1986-10-09 アンスチチュ　パストゥール Therapeutical medicine for acquired immunological dysfunction syndrome, pharmacological composition and therapy
JPH0262533B2 (en) * 1984-12-03 1990-12-26 Ansuchi* Pasutsuuru
JPS6438022A (en) * 1987-08-03 1989-02-08 Haruhisa Fujita Antiviral agent

Also Published As

Publication number Publication date
GB1573002A (en) 1980-08-13
JPS6120525B2 (en) 1986-05-22

Similar Documents

Publication Publication Date Title
JPS5275893A (en) Method and device for preventing snore
JPS51122983A (en) Incising device and method thereof
MY8500125A (en) Composition and method for combating virus infections
JPS5282874A (en) Incineration method and apparatus
JPS5329942A (en) Hair pretratment compound and hair treatment process
JPS51118767A (en) Benzomorphan derivatives and preparation method
JPS51132369A (en) Limit stopping method and apparatus
PH12185A (en) Mucolytic compounds and method of treatment thereof
PT64819A (en) Brake apparatus and method
PT65601B (en) Hypolipemic compounds and method of treatment
JPS5486605A (en) Erythromicine treating method
PH12221A (en) Micro-gasometric method and apparatus
JPS5239684A (en) Compounds having antiiinflammation and preparation method thereof
JPS5240649A (en) Falseetwisting method and apparatus
JPS5294431A (en) Antiivirus agent treatment for virus inffction and prevention method
JPS5279921A (en) Method and device for treating film
JPS5223888A (en) Disinfecting method and apparatus
JPS53115810A (en) Treating and preventing agent for hyperlipidemia
JPS5254436A (en) Method and device for treating original
JPS51140311A (en) Soil treatment agent
CS189030B2 (en) Fundicide means and method of making the active agent
MW4676A1 (en) Method for the treatment of sugarcance
JPS5266634A (en) Waterreczema treating agent and process for preparing same
JPS5238655A (en) Method and device for treating electrode
JPS5281027A (en) Descaling agent and method